Cellect Biotechnology (APOP) Stock Price, News & Analysis

Company Overview

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.

Key Stats

• Today's Range: N/A
• 50-Day Range: $7.54 to $13.40
• 52-Week Range: N/A
• Volume: 17,400 shs
• Average Volume: 479,845 shs
• Market Capitalization: $12.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

APOP Stock Analysis - Frequently Asked Questions

How were Cellect Biotechnology's earnings last quarter?

Cellect Biotechnology Ltd. (NASDAQ:APOP) released its quarterly earnings data on Tuesday, November, 13th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.56) by $0.02.

When did Cellect Biotechnology's stock split?

Shares of Cellect Biotechnology split on Tuesday, October 26th 2021.The 2-1 split was announced on Tuesday, October 26th 2021. The newly created shares were distributed to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What other stocks do shareholders of Cellect Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Advanced Micro Devices (AMD), NVIDIA (NVDA), Acasti Pharma (ACST) and Corbus Pharmaceuticals (CRBP).

Company Calendar

• Last Earnings: 11/13/2018
• Today: 7/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:APOP
• CIK: 1671502
• Web: www.cellect.co
• Phone: (729) 974-1444
• Fax: 972-9767-8750
• Employees: 2,020
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.01
• Quick Ratio: 3.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.77 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 977,000
• Free Float: N/A
• Market Cap: $12.87 million
• Optionable: Not Optionable
• Beta: 1.87